A Qaseem, V Snow, JT Cross, MA Forciea, R … - Annals of Internal Medicine, 2008 - Am Coll Physicians From the American College of Physicians and University of Pennsylvania,
Philadelphia, Pennsylvania; Medstudy, Colorado Springs, Colorado; University of
Arkansas, Little Rock, Arkansas; Veterans Affairs Greater Los Angeles ... Cited by 34 - Related articles - BL Direct - All 31 versions
P Raina, P Santaguida, A Ismaila, C … - Annals of Internal Medicine, 2008 - Am Coll Physicians Purpose: To review the evidence for the effectiveness of cholinesterase
inhibitors (donepezil, galantamine, rivastigmine, and tacrine) and the
neuropeptide-modifying agent memantine in achieving clinically relevant ... Cited by 70 - Related articles - BL Direct - All 10 versions
A Qaseem, V Snow, P Shekelle, R Hopkins, … - Annals of Internal Medicine, 2008 - Am Coll Physicians Methods: Published literature on this topic was identified by using MEDLINE
(1966 to December 2006), the ACP Journal Club database, the Cochrane Central
Register of Controlled Trials (no date limits), the Cochrane Database of ... Cited by 21 - Related articles - All 5 versions
B Winblad, G Grossberg, L Frolich, M Farlow, … - Neurology, 2007 - AAN Enterprises The rivastigmine patch is the first transdermal treatment for Alzheimer disease
(AD). By providing continuous delivery of drug into the bloodstream over 24
hours, transdermal delivery may offer benefits superior to those of oral ... Cited by 34 - Related articles - All 5 versions
G Waldemar, M Hyvarinen, MK Josiassen, A … - Int J Geriatr Psychiatry, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 6 - Related articles - All 2 versions
C MacLean, S Newberry, M Maglione, M … - Annals of Internal Medicine, 2008 - Am Coll Physicians From the Southern California Evidence-based Practice Center, which includes
RAND, Santa Monica, and the Greater Los Angeles Veterans Administration
Healthcare System and the David Geffen School of Medicine at the University ... Cited by 79 - Related articles - All 5 versions
S Gauthier, H Loft, J Cummings - International journal of geriatric psychiatry, 2008 - legemiddelsiden.no SUMMARY Introduction Behavioural disturbances are a common and distressing
aspect of Alzheimer's disease (AD). This pooled analysis evaluated the specific
benefits of memantine on behavioural disturbances in patients with moderate ... Cited by 17 - Related articles - View as HTML - BL Direct - All 6 versions
S Mayor - Bmj, 2005 - bmjcom.highwire.org The manufacturer, Johnson & Johnson Pharmaceutical Research & Development, made
the announcement last week, following two trials that it conducted. The studies
combined included 2048 people aged 50 years and over with mild cognitive ... Cited by 17 - Related articles - All 6 versions
P Calabrese, U Essner, H Forstl - Dement Geriatr Cogn Disord, 2007 - content.karger.com Alzheimer's disease (AD) is a progressive neurodegen- erative condition. In
Germany, there are an estimated 900,000 patients with dementia, of whom 650,000
suffer from AD [1] . Every year, 200,000 new cases of dementia are ... Cited by 6 - Related articles - BL Direct - All 7 versions
- ►nih.gov MJL Graff, EMM Adang, MJM Vernooij-Dassen, … - British Medical Journal, 2008 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objective To assess the ... Cited by 19 - Related articles - All 9 versions
